TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.
about
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesFrequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulationManagement of gastric and duodenal neuroendocrine tumorsNeuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewClinical features of gastroenteropancreatic tumoursNeuroendocrine differentiation: The mysterious fellow of colorectal cancerNon-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and managementEndoscopic diagnosis and management of type I neuroendocrine tumorsPET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literaturePulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsRecent developments in imaging of pancreatic neuroendocrine tumorsImaging of gastroenteropancreatic neuroendocrine tumorsNeuroendocrine pancreatic tumors: guidelines for management and updateNeuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upGastrointestinal neuroendocrine tumors: pancreatic endocrine tumorsNeuroendocrine tumors of the gastro-entero-pancreatic systemStreptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment StratificationContrast-enhanced ultrasound of pancreatic tumours.Everolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data.Radiolabeled somatostatin analogues therapy in advanced neuroendocrine tumors: a single centre experienceContinuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network.Non-functioning pancreatic neuroendocrine tumors: Surgery or observation?Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systemsPrognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center.Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors.Comparison of relapse-free survival in gastric neuroendocrine carcinoma (WHO grade 3) and gastric carcinoma.Insights into gastric neuroendocrine tumors burdenClinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in ChinaPrognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors.Hepatobiliary neuroendocrine carcinoma: a case report.Clinicopathological features and surgical outcomes of neuroendocrine tumors of ampulla of VaterMolecular characteristics and predictors of survival in patients with malignant neuroendocrine tumors.Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapiesDiagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation.Developing a multivariable prognostic model for pancreatic endocrine tumors using the clinical data warehouse resources of a single institution.Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.Expression of O(6)-methylguanine DNA methyltransferase (MGMT) and its clinical significance in gastroenteropancreatic neuroendocrine neoplasmNeuroendocrine tumors of the gastrointestinal tract: Case reports and literature review.
P2860
Q24603675-29CD17A1-CED0-4934-B661-E5D5D3FB034DQ24655168-D6EAD08C-7EE4-4A85-9F7B-63947A68389FQ26738541-70ADEC83-2D40-432D-BB3B-F93DC49E3787Q26768483-4C58D347-4B5F-4E9A-82B7-C0DC2BEEE371Q26777896-2B09C255-CFE8-4DA9-B889-EFCA4EA3197AQ26778012-34A4FF08-7013-4AE4-BA12-8894E6C1008BQ26795597-F84EB6D6-9FDC-492C-B646-41A7B6CAF809Q26824302-235942CA-E098-4DC2-90F2-D8E3938D9230Q26992201-BC2AE5A5-58B1-4D1D-9B2F-D9EAF8A8B5C7Q26996521-C24C6780-55B3-4251-977E-33CBC64355FAQ27005697-84C56C59-BEC9-4B96-9C9C-90075CB4FAF1Q28238305-1B01C661-73E8-400E-95D1-D57D5C0449F3Q28256132-838C4AE9-8139-483B-A865-3CF9179ED2DBQ28285545-76197B34-2610-41E3-87D5-8141D453F348Q28290833-D4F407DD-1575-4645-BE0F-157252E4ABD8Q28294432-EC876C3F-595F-4C63-B035-50C5A860B4E7Q28551275-C714C4A7-0586-4276-8A50-8C9A9306ADBEQ30363460-787B1355-D10C-412F-9B9C-6DBE43EFFE0CQ30884794-E69BCAF0-A012-4E00-9ACA-94693DB30DF9Q33403035-45557D99-439F-4E0C-B319-D3242F2A433AQ33514751-EC8B84D3-5987-400D-B035-8185C7FD413AQ33573118-AB6ECB31-D1D6-4B12-ACB5-378FDCE25D94Q33591842-0FDF527F-2165-4F87-B7A2-BF871942AE3CQ33597784-1902F2A4-C13F-4BD1-8886-D9DAEC36BE46Q33598860-A875CDB2-B948-46F4-913C-36A747A68373Q33632569-A6891281-E3B0-4922-AC83-B083DA7B509BQ33649959-8C808F86-3B43-44CB-8DE7-F911FCAD6F84Q33684746-C0840007-8EEE-4F48-B15B-1E42BA582EB1Q33708663-1209839C-3940-4F02-A53C-98106B2EE7B1Q33718655-27A2F268-5871-4BBA-9B50-B81A0376306DQ33750527-28FEA732-19DA-4714-9791-B8A7233E7165Q33775632-6649ECDA-AD8D-4180-AB50-E6505942A648Q33783119-8F4C7858-C65B-442F-91DC-369785194DF5Q33823783-654BE8F1-3070-45CD-A9FD-50E494C39CEDQ33840177-4FB8D0AD-4ACE-4F1D-9FE6-33455ED3AC73Q33863393-3B66BCD3-3CE3-4E13-BE25-5284FBD649CEQ33892438-1DC266E0-A457-4CC0-A577-3BC6EBCE5CA6Q33894587-D809EFC2-061C-47AF-9994-382E1A422A11Q34029197-A48B5899-57F5-4664-9DA3-D5D507684391Q34049125-F9BF3EF8-71F8-455A-860D-EF1C0941B019
P2860
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
TNM staging of foregut (neuro) ...... al including a grading system.
@ast
TNM staging of foregut (neuro) ...... al including a grading system.
@en
type
label
TNM staging of foregut (neuro) ...... al including a grading system.
@ast
TNM staging of foregut (neuro) ...... al including a grading system.
@en
prefLabel
TNM staging of foregut (neuro) ...... al including a grading system.
@ast
TNM staging of foregut (neuro) ...... al including a grading system.
@en
P2093
P2860
P50
P1433
P1476
TNM staging of foregut (neuro) ...... sal including a grading system
@en
P2093
A Couvelard
A-M McNicol
B Erikssson
B Wiedenmann
European Neuroendocrine Tumor Society (ENETS)
J-Y Scoazec
P2860
P2888
P304
P356
10.1007/S00428-006-0250-1
P577
2006-09-12T00:00:00Z